The Medicines Company to Host Investor Day on January 23, 2018
December 13 2017 - 7:00AM
Business Wire
The Medicines Company (NASDAQ:MDCO) today announced that it will
host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m.
to 12:30 p.m., Eastern Time, in New York City.
The event will be led by Fred Eshelman, Pharm.D., Executive
Chairman of The Medicines Company, and Clive Meanwell, M.D., Ph.D.,
Chief Executive Officer of the Company, who will be joined by
members of the Company’s management team and outside experts and
key members of the ORION coalition, including:
- Eugene Braunwald, M.D., Distinguished
Hersey Professor of Medicine at Harvard Medical School and founding
Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study
Group;
- John J.P. Kastelein, M.D., Ph.D.,
Professor of Medicine and Chairman of the Department of Vascular
Medicine at the Academic Medical Center of the University of
Amsterdam; and
- Marc S. Sabatine M.D., M.P.H., Lewis
Dexter, M.D., Distinguished Chair in Cardiovascular Medicine at
Brigham and Women’s Hospital, Professor of Medicine at Harvard
Medical School and Chairman of the TIMI Study Group.
Presentations and panel discussions will focus on inclisiran,
its highly-differentiated value proposition and clinical and
non-clinical development, manufacturing, regulatory and
pre-commercial projects, as well as on the continuing, unmet
medical and market needs in atherosclerotic cardiovascular
disease.
The event will be broadcast live via webcast. To access the live
webcast and view the accompanying slide presentation, visit the
“Investors - Events/Presentations” section of The Medicines Company
website at least 15 minutes before the event is scheduled to begin
to register and download or install any necessary software. In
addition to the webcast, the event can be accessed, in listen-only
mode, as follows:
U.S./Canada: (877) 359-9508
International: (224) 357-2393 Conference ID: 60380330
A replay of the webcast will be archived and available after the
event for a limited period of time.
The in-person event is reserved for financial analysts and
institutional investors and is by invitation only.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by
an overriding purpose – to save lives, alleviate suffering and
contribute to the economics of healthcare. The Company’s mission is
to create transformational solutions to address the most pressing
healthcare needs facing patients, physicians and providers in
serious infectious disease care and cardiovascular care. The
Company is headquartered in Parsippany, New Jersey, with a global
innovation center in California.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171213005295/en/
The Medicines CompanyMediaMeg Langan, 973-290-6319Vice
Presidentmargaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D.,
973-290-6122Vice President, Investor
Relationskrishna.gorti@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Apr 2023 to Apr 2024